Understanding causes of incomplete reports of adverse drug reactions associated with dolutegravir-based HIV treatment in uganda: a qualitative study

Health workers perceived factors underpinning incomplete DTG-associated ADR reports in Uganda as stemming from patient-based factors (e.g. non-disclosure of concomitant use of herbal medicines), health workforce-drivers (e.g. 'professional agency' in responding to ADRs) and health system constraints (lack of incentives for reporting). The policy and programming implications for improving data quality in reporting DTG-associated ADRs in Uganda and countries with similar setting are discussed.

Authors

Institutions

Publication Details

Journal
BMC Infectious Diseases
Published
2025-11-03
DOI
https://doi.org/10.1186/s12879-025-11592-0
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Understanding causes of incomplete reports of adverse drug reactions associated with dolutegravir-based HIV treatment in uganda: a qualitative study

Joanitah Atuhaire, Helen Byomire Ndagije, Henry Zakumumpa, Ronald Kiguba et al.
BMC Infectious Diseases
HIV/AIDS drug development and treatment
article

Understanding causes of incomplete reports of adverse drug reactions associated with dolutegravir-based HIV treatment in uganda: a qualitative study

Joanitah Atuhaire, Helen Byomire Ndagije, Henry Zakumumpa, Ronald Kiguba, Julius Mayengo, Francis Odipiyo
article en

Abstract

Health workers perceived factors underpinning incomplete DTG-associated ADR reports in Uganda as stemming from patient-based factors (e.g. non-disclosure of concomitant use of herbal medicines), health workforce-drivers (e.g. 'professional agency' in responding to ADRs) and health system constraints (lack of incentives for reporting). The policy and programming implications for improving data quality in reporting DTG-associated ADRs in Uganda and countries with similar setting are discussed.

BMC Infectious DiseasesVol. 25(1)
Makerere University (UG)
Openalex Percentile: Top 62%
HIV/AIDS drug development and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Understanding causes of incomplete reports of adverse drug reactions associated with dolutegravir-based HIV treatment in uganda: a qualitative study — Joanitah Atuhaire, Helen Byomire Ndagije, et al. · BMC Infectious Diseases (2025) | TGRS Research Map | TGRS